PubMed:32829416 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/32829416","sourcedb":"PubMed","sourceid":"32829416","source_url":"https://www.ncbi.nlm.nih.gov/pubmed/32829416","text":"The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.\n","tracks":[{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":144},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":144},"obj":"Sentence"}],"attributes":[{"subj":"T1","pred":"source","obj":"Inflammaging"},{"subj":"T1","pred":"source","obj":"Inflammaging"}]},{"project":"sentences","denotations":[{"id":"T1","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T1","pred":"source","obj":"sentences"}]},{"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":136,"end":143},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"subj":"T1","pred":"source","obj":"mondo_disease"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#d2ec93","default":true},{"id":"sentences","color":"#ec93ec"},{"id":"mondo_disease","color":"#93ecd2"}]}]}}